This inventor holds 1 USPTO granted patent. Top assignee: Nervana, LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Richard S. Williams
Introduction
Richard S. Williams is a notable inventor based in Redwood City, CA (US). He has made significant strides in the field of medical technology, particularly with his innovative approach to neural treatment. His work focuses on addressing various clinical indications, including peripheral neuropathy, through advanced techniques.
Latest Patents
Richard S. Williams holds a patent for a "Transvenous cryoneurolysis system, devices and methods." This patent introduces a transvenous approach for accessing and targeting neural treatment sites. The system aims to relieve a variety of clinical indications by utilizing a neurosome approach that selectively targets nerves for cryoneurolysis via a target vein. The method involves performing different freeze and thaw cycles to achieve a desired thermal treatment temperature range, allowing for selective sensory loss while minimizing impact on associated motor nerves. This innovative technique combines pain relief with the regenerative properties of cryoneurolysis.
Career Highlights
Richard is currently associated with Nervana, LLC, where he continues to develop and refine his groundbreaking technologies. His work has the potential to transform the way neural treatments are approached, offering new hope for patients suffering from chronic pain conditions.
Collaborations
Richard has collaborated with talented individuals such as Bhavraj Khalsa and Ali Golshan, contributing to the advancement of medical technologies and enhancing the effectiveness of their innovations.
Conclusion
Richard S. Williams exemplifies the spirit of innovation in the medical field through his pioneering work in cryoneurolysis. His contributions are paving the way for new treatment options that can significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile